13F-HR filed by Atle Fund Management AB
Atle Fund Management AB filed this 13F-HR for the quarter ended 2017-12-31, filed 2018-02-09, with 16 holding rows worth $47,384,000.
- Accession
- 0000950123-18-001157
- Filer
- CIK 1381843
- Filed
- 2018-02-09
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2017
A holdings report, 16 entries on the cover page, a total value of $47,384,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $47,385,000 with VALUE read as thousands by filing date, 13F file number 028-12171. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ANIKA THERAPEUTICS INC | 035255108 | COM | 114,600 | $6,178,000 | thousands by filing date | |
| CHARLES RIV LABS INTL INC | 159864107 | COM | 26,712 | $2,924,000 | thousands by filing date | |
| LABORATORY CORP OF AMERICA | 50540R409 | COM NEW | 17,800 | $2,839,000 | thousands by filing date | |
| QUEST DIAGNOSTICS INC COM | 74834L100 | Stock | 28,500 | $2,807,000 | thousands by filing date | |
| CARDINAL HEALTH INC | 14149Y108 | COM | 45,600 | $2,794,000 | thousands by filing date | |
| MCKESSON CORP COM | 58155Q103 | Stock | 17,800 | $2,776,000 | thousands by filing date | |
| Elevance Health, Inc. | 036752103 | COM | 12,300 | $2,768,000 | thousands by filing date | |
| LIGAND PHARMACEUTICALS INC | 53220K504 | COM NEW | 20,200 | $2,766,000 | thousands by filing date | |
| Medtronic Plc | G5960L103 | COM | 34,200 | $2,762,000 | thousands by filing date | |
| CIGNA CORPORATION | 125509109 | COM | 13,400 | $2,721,000 | thousands by filing date | |
| Pfizer Inc. | 717081103 | COM | 75,100 | $2,720,000 | thousands by filing date | |
| WATERS CORP COM | 941848103 | Stock | 14,000 | $2,705,000 | thousands by filing date | |
| Eli Lilly and Company | 532457108 | COM | 32,000 | $2,703,000 | thousands by filing date | |
| BIOGEN INC COM | 09062X103 | Stock | 8,400 | $2,676,000 | thousands by filing date | |
| Bristol-Myers Squibb Company | 110122108 | COM | 43,400 | $2,660,000 | thousands by filing date | |
| Gilead Sciences,Inc. | 375558103 | COM | 36,100 | $2,586,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000950123-18-001157 | this filing | 2018-02-09 | acceptance time not in the bulk data set |